Interaction Checker

About Us
Mission Statement Meet the Team Steering Committee
Interaction Checkers
Interaction Checker View All Checker
Prescribing Resources Site News Contact Us
If a drug is not listed below it cannot automatically be assumed it is safe to coadminister.

COVID Drugs

Selected Drugs will be displayed here.

  • {{drug.name}}

    Drug Class: {{drug.drug_class_name || 'Not Available'}}

    Trade Name: {{vm.getTradeNames(drug)}}

  • {{drug.name}}

    Drug Class: {{drug.drug_class_name || 'Not Available'}}

    Trade Name: {{vm.getTradeNames(drug)}}

  • {{drugClass.name}}
    • {{drug.name}}

      Drug Class: {{drug.drug_class_name || 'Not Available'}}

  • {{tradeName.name}}
    • {{drug.name}}

      Drug Class: {{drug.drug_class_name || 'Not Available'}}

      Trade Name: {{vm.getTradeNames(drug)}}

Co-medications

Selected Co-medications will be displayed here

  • {{drug.name}}

    Drug class: {{drug.drug_class_name || 'Not Available'}}

    Trade Name: {{vm.getTradeNames(drug)}}

  • {{drug.name}}

    Drug class: {{drug.drug_class_name || 'Not Available'}}

    Trade Name: {{vm.getTradeNames(drug)}}

  • {{drugClass.name}}
    • {{drug.name}}

      Drug Class: {{drug.drug_class_name || 'Not Available'}}

  • {{tradeName.name}}
    • {{drug.name}}

      Drug Class: {{drug.drug_class_name || 'Not Available'}}

      Trade Name: {{vm.getTradeNames(drug)}}

Drug Interactions

Check COVID/COVID drug interactions

Drug Interactions will be displayed here

Reset Checker
Switch to table view Results Key

Drug combinations may have been assessed either by study or within the product label, or an interaction may have been predicted based on the metabolic profiles of the drugs.

These drugs should not be coadministered

Potential clinically significant interaction that is likely to require additional monitoring, alteration of drug dosage or timing of administration.

Potential interaction likely to be of weak intensity. Additonal action/monitoring or dosage adjustment is unlikely to be required

No clinically significant interaction expected

{{vm.interactionSummary(interaction)}}

{{interaction.primary_drug_name}}

{{interaction.co_drug_name}}

Look for alternatives

More Info

Quality of Evidence: {{vm.calculateEvidenceGrade(interaction.evidence_grade)}}

Summary:

Not Available

Description:

Not Available

{{vm.interactionSummary(interaction)}}

{{interaction.primary_drug_name}}

{{interaction.co_drug_name}}

Quality of Evidence: {{vm.calculateEvidenceGrade(interaction.evidence_grade)}}

Summary:

Not Available

Description:

Not Available

Open in new tab

Do Not Coadminister

Potential Interaction

Potential Weak Interaction

No Interaction Expected

Results Key

Drug combinations may have been assessed either by study or within the product label, or an interaction may have been predicted based on the metabolic profiles of the drugs.

These drugs should not be coadministered

Potential clinically significant interaction that is likely to require additional monitoring, alteration of drug dosage or timing of administration.

Potential interaction likely to be of weak intensity. Additonal action/monitoring or dosage adjustment is unlikely to be required

No clinically significant interaction expected

{{col.name}}
{{row.name}}

Generate a personalised report in PDF format

Download PDF
Academic Sponsors / Collaborators
Editorial Sponsors / Research Funders
Cookie Policy Privacy Statement Terms & Conditions

Copyright © 2024 The University of Liverpool. All rights reserved.